Tata India Pharma & Healthcare Fund vs DSP Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1232 Cr | ₹2961 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 28 Dec 2015 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 18% |
Expense Ratio | 2.14 | 1.9 |
Manager | Meeta Shetty | Jay Kothari |
ISIN Code | INF277K016A9 | INF740KA1LD8 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | 3.27% | 3.09% |
6 Month | -4.33% | -5.84% |
1 Year | 15.17% | 16.86% |
3 Year | 25.14% | 26.47% |
5 Year | 21.99% | 23.37% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | 5.28% | 3.01% |
1 Year | 3.14% | -1.29% |
3 Year | 23.44% | 22.48% |
5 Year | 19.45% | 19.14% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 9.47% | 26.81% |
3 Year | 18.04% | 20.65% |
5 Year | 14.89% | 27.26% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 16.16% | 15.13% |
Sharp | 0.95% | 1.04% |
Beta | 0.98% | 0.86% |
Alpha | -0.66% | 1.69% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Meeta Shetty | Jay Kothari |
Total AUM | ₹17847 Cr | ₹0 Cr |
Funds Managed | 5 | 20 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 5.06 | 18.5 |
Small Cap | 27.82 | 49.08 |
Large Cap | 35.26 | 18.51 |
Mid Cap | 31.87 | 13.9 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 4.34 | 1.47 |
Basic Materials | 2.22 | - |
Healthcare | 93.44 | 97.13 |
Financial Services | - | 1.4 |
Top Comparisons
Franklin India Equity Hybrid Fund - Growth Plan
3Y Returns19.15%
LIC MF Equity Hybrid Fund-Growth
3Y Returns17.04%
Mirae Asset Arbitrage Fund Regular Growth
3Y Returns6.71%
HSBC Arbitrage Fund - Regular Growth
3Y Returns6.62%
Aditya Birla SL Crisil IBX Gilt June 2027 Index Fund-Reg (G)
3Y Returns0%
UTI QUARTERLY INTERVAL FUND II REGULAR PLAN GROWTH
3Y Returns6.03%
SBI Magnum Medium Duration Fund - Regular Plan - Growth
3Y Returns7.86%
SUNDARAM MEDIUM DURATION FUND Regular Plan - Growth
3Y Returns6.09%